Product Information
OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Cipla USA Inc., priced at $0.1519 per ML under NDC 69097090443. Its NADAC has been published 120 times since Nov 8, 2023.
FDA first approved this application on Aug 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6 mg/mL
Manufacturer
Cipla USA Inc.NDC
69097090443
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA212858FDA Approved
8/30/2021
TE Code
AB
On Market Since
1/16/2023
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 120 times since Nov 8, 2023, and over the history we have for it it has declined 40.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1519 per ML |
|---|---|
| All-time high | $0.2776 (Jan 10, 2024) |
| All-time low | $0.1271 (Nov 20, 2024) |
| 52-week high | $0.1739 |
| 52-week low | $0.1519 |
| Median price | $0.1982 |
| Average price | $0.1981 |
| Largest weekly change | +38.5% (Dec 18, 2024) |
| Weeks tracked | 120 |
| Tracking since | Nov 8, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-12.7%
3Y
N/A
5Y
N/A
All
-40.8%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OSELTAMIVIR PHOSPHATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Cipla USA Inc., is $0.1519 per ML (NDC 69097090443), effective Feb 18, 2026.
How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 40.8%. It has been tracked across 120 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?
Since Nov 8, 2023, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $0.2776 (Jan 10, 2024), with a median of $0.1982 per ML.
Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OSELTAMIVIR 6 MG/ML SUSPENSION, is $0.1496 per ML — about 1% below OSELTAMIVIR 6 MG/ML SUSPENSION.
Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?
OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 69097090443) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.